Arcadia Biosciences Cash Flow - Quarterly (NASDAQ:RKDA)

Add to My Stocks
$6.33 $0.75 (13.44%) RKDA stock closing price Aug 17, 2018 (Closing)

The cash flow statement is one of the reports a publicly traded company like Arcadia Biosciences needs to disclose. The profit-loss statement shows Arcadia Biosciences profits, the balance sheet shows Arcadia Biosciences debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. Arcadia Biosciences stock analysis shows negative net income cash flow of $-17.28M till 2018 Q2. This statement is important because profits alone cannot pay employees, or bills. Cash is required. The cash from operating activities for Arcadia Biosciences is $ 2018 Q2, which saw a decrease from previous quarter.

View and download details of Arcadia Biosciences cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow----------
Net Increase (Decrease) in Assets Liabilities---0.92M-0.84M-1.63M-0.77M--0.01M--0.07M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net9.63M7.09M2.47M2.17M--1.26M---
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.06M-0.02M-0.07M-0.07M-0.05M-0.05M-0.23M-0.22M-0.19M-0.13M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments-15.01M3.9M47.25M38.37M20.38M10.11M-5.07M-0.88M12.2M10.46M
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares24.97M10.96M--------
Issuance (Repayment) of Debt Securities---25M-25M------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-2.44M-0.93M-1.12M-1.12M---0.04M-0.04M-0.04M-0.04M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year9.13M2.01M23.97M16.57M2.83M5.35M----
Cash & Equivalents at Year End9.67M20.41M9.12M2.93M13.43M7.55M2.01M10.47M27.36M29.54M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Arcadia Biosciences stock price history provides insight into historical stock price fluctuations, and Arcadia Biosciences stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Arcadia Biosciences has cash of $9.67M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Arcadia Biosciences stock price.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-6.92M for RKDA.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-15.07M for RKDA till last quarter 2018 Q2 report.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $22.53M for Arcadia Biosciences. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For Arcadia Biosciences Cash Flow

Quarterly Cash Flow Statements For Arcadia Biosciences Inc Peers

Bayer AG cash flow, GROWGENERATION cash flow, Scotts Miracle-Gro cash flow, VITALITY BIOPHM cash flow